168 related articles for article (PubMed ID: 36362241)
41. Generation and epitope analysis of human monoclonal antibody isotypes with specificity for the Timothy grass major allergen Phl p 5a.
Hecker J; Diethers A; Etzold S; Seismann H; Michel Y; Plum M; Bredehorst R; Blank S; Braren I; Spillner E
Mol Immunol; 2011 May; 48(9-10):1236-44. PubMed ID: 21474184
[TBL] [Abstract][Full Text] [Related]
42. Necessity of the stalk region for immunoglobulin E interaction with CD23.
Chen BH; Ma C; Caven TH; Chan-Li Y; Beavil A; Beavil R; Gould H; Conrad DH
Immunology; 2002 Nov; 107(3):373-81. PubMed ID: 12423314
[TBL] [Abstract][Full Text] [Related]
43. Application of human Fc epsilon RI alpha-chain-transfected RBL-2H3 cells for estimation of active serum IgE.
Takagi K; Nakamura R; Teshima R; Sawada J
Biol Pharm Bull; 2003 Feb; 26(2):252-5. PubMed ID: 12576689
[TBL] [Abstract][Full Text] [Related]
44. Chimeric Antigen Receptors Based on Low Affinity Mutants of FcεRI Re-direct T Cell Specificity to Cells Expressing Membrane IgE.
Ward DE; Fay BL; Adejuwon A; Han H; Ma Z
Front Immunol; 2018; 9():2231. PubMed ID: 30364107
[TBL] [Abstract][Full Text] [Related]
45. Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potency.
Saul L; Josephs DH; Cutler K; Bradwell A; Karagiannis P; Selkirk C; Gould HJ; Jones P; Spicer JF; Karagiannis SN
MAbs; 2014; 6(2):509-22. PubMed ID: 24492303
[TBL] [Abstract][Full Text] [Related]
46. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
47. Anti-IgE monoclonal antibodies directed at the Fc epsilon receptor binding site.
Baniyash M; Kehry M; Eshhar Z
Mol Immunol; 1988 Aug; 25(8):705-11. PubMed ID: 2460756
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of allergic reactions with monoclonal antibody to the high affinity IgE receptor.
Kitani S; Kraft D; Fischler C; Mergenhagen SE; Siraganian RP
J Immunol; 1988 Apr; 140(8):2585-8. PubMed ID: 2451693
[TBL] [Abstract][Full Text] [Related]
49. Affinity-purified soluble Fc epsilon RII/CD23 derived from RPMI-8866 cells induces histamine release from human nasal polyp mast cells through a non-IgE-mediated mechanism.
Ghaderi AA; Jones VM; Stanworth DR
Immunol Lett; 1991 Feb; 27(2):113-8. PubMed ID: 1709143
[TBL] [Abstract][Full Text] [Related]
50. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
51. An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells.
Sharquie IK; Al-Ghouleh A; Fitton P; Clark MR; Armour KL; Sewell HF; Shakib F; Ghaemmaghami AM
BMC Immunol; 2013 Dec; 14():54. PubMed ID: 24330349
[TBL] [Abstract][Full Text] [Related]
52. Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils.
El Ansari YS; Kanagaratham C; Burton OT; Santos JV; Hollister BA; Lewis OL; Renz H; Oettgen HC
Front Immunol; 2022; 13():881655. PubMed ID: 35865546
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the IgE receptor by tryptic mapping.
Pecoud AR; Conrad DH
J Immunol; 1981 Dec; 127(6):2208-14. PubMed ID: 7299127
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of IgE binding to RBL-2H3 cells by a monoclonal antibody (BD6) to a surface protein other than the high affinity IgE receptor.
Hamawy MM; Oliver C; Siraganian RP
J Immunol; 1992 Jan; 148(2):524-31. PubMed ID: 1370314
[TBL] [Abstract][Full Text] [Related]
55. Purification of murine suppressive factor of allergy into distinct CD23-modulating and IgE-suppressive proteins.
Matsushita S; Marcelletti JF; Katz LR; Katz DH
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4718-22. PubMed ID: 1828884
[TBL] [Abstract][Full Text] [Related]
56. Structural and Physical Basis for Anti-IgE Therapy.
Wright JD; Chu HM; Huang CH; Ma C; Chang TW; Lim C
Sci Rep; 2015 Jun; 5():11581. PubMed ID: 26113483
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibody AA4, which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells, binds to novel alpha-galactosyl derivatives of ganglioside GD1b.
Guo NH; Her GR; Reinhold VN; Brennan MJ; Siraganian RP; Ginsburg V
J Biol Chem; 1989 Aug; 264(22):13267-72. PubMed ID: 2526814
[TBL] [Abstract][Full Text] [Related]
58. Epitope mapping of the site(s) of binding of Fc epsilon RII/CD23 within human IgE. Determination of the B lymphocyte-binding sites by use of synthetic peptides and anti-peptide antibodies representative of linear Fc sequences.
Ghaderi AA; Stanworth DR
Mol Immunol; 1993 Dec; 30(18):1655-63. PubMed ID: 7505881
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE.
Rao M; Lee WT; Conrad DH
J Immunol; 1987 Mar; 138(6):1845-51. PubMed ID: 2950171
[TBL] [Abstract][Full Text] [Related]
60. Association of the crosslinked IgE receptor with the membrane skeleton is independent of the known signaling mechanisms in rat basophilic leukemia cells.
Apgar JR
Cell Regul; 1991 Mar; 2(3):181-91. PubMed ID: 1830493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
